Gesco (GSC1) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
6 Jun, 2025Executive summary
Q1 2025 started as expected, with order intake stable year-over-year at €132.1 million (adjusted prior year: €132.8 million).
Sales rose 6% on an adjusted basis to €121.7 million (prior year adjusted: €114.7 million), but declined 2.1% unadjusted due to divestitures.
Group earnings after minority interests increased 12.9% to €2.0 million; EPS up 21.8% to €0.19.
Workforce reduced to 1,471, mainly due to the sale of AstroPlast and Doerrenberg divisions at end-2024.
Financial highlights
EBITDA was €8.2 million, down 4.6% year-over-year; EBIT rose 1.5% to €4.1 million.
EBT increased 8.8% to €3.2 million; net income after minorities at €2.0 million.
Equity ratio at 61.7%, slightly down from 62.3% at year-end 2024; total assets up 1.2% to €438.7 million.
Cash and cash equivalents at €31.1 million, with a solid balance sheet and low gearing.
Outlook and guidance
2025 sales expected at €485–515 million (2024 adj.: €480.1 million); net income after minorities forecast at €13–17 million (2024 adj.: €13.1 million).
Forecast excludes planned transactions; outlook shaped by geopolitical and economic uncertainties.
Latest events from Gesco
- Earnings and EBIT surged despite lower revenue, but 2025 guidance was revised downward.GSC1
Q3 202516 Apr 2026 - 2025 profit more than doubled as EBIT improved; 2026 outlook is positive but volatile.GSC1
H2 202515 Apr 2026 - Earnings and margins improved despite lower sales and orders, with stable 2025 guidance.GSC1
H1 202515 Apr 2026 - Sales and earnings fell, but GESCO upholds robust guidance for 2024.GSC1
Q3 202413 Jun 2025 - Sales and earnings fell significantly in H1 2024, prompting a downward revision of full-year guidance.GSC1
H1 202413 Jun 2025 - Sales and earnings fell sharply in 2024, but GESCO enters 2025 leaner and financially strong.GSC1
H2 20249 Jun 2025